XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Product Information [Line Items]      
Cash FDIC insurance $ 250,000   $ 500,000
Legal and filing fees and costs $ 56,084 $ 83,211  
Foreign currency average rate 1.0516 1.0848  
Other costs and expenses $ 81,338 $ 147,645  
Related Party [Member]      
Product Information [Line Items]      
Legal and filing fees and costs   317,662  
Other costs and expenses   $ 446,942  
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 10.00% 10.00%  
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 9.10% 9.80%  
General And Administrative [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant One [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 13.10%    
General And Administrative [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Two [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 10.10%    
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant One [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 30.70% 56.20%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Two [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 17.10% 19.10%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant [Member]      
Product Information [Line Items]      
Concentration of risk, percentage   14.70%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor and Consultant Three [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 15.30% 12.80%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor and Consultant Four [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 15.10%    
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor and Consultant Five [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 14.70%    
Stock Options Granted to Directors and Corporate Officers [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration of risk, percentage 16.20% 12.10%